UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of Affinity‐Based Probes for Btk Occupancy Assays

ChemMedChem, 2019-01, Vol.14 (2), p.217-223

2019

Volltextzugriff (PDF)

Understanding User-Librarian Interaction Types in Academic Library Microblogging: A Comparison Study in Twitter and Weibo

The Journal of academic librarianship, 2017-07, Vol.43 (4), p.329-336

2017

Volltextzugriff (PDF)

BCL2L1 is associated with γ-globin gene expression

Blood advances, 2019-10, Vol.3 (20), p.2995-3001

2019

Volltextzugriff (PDF)

Creation of the First Anomeric D/L-Sugar Kinase by Means of Directed Evolution

Proceedings of the National Academy of Sciences - PNAS, 2003-11, Vol.100 (23), p.13184-13189

2003

Volltextzugriff (PDF)

Ability of Bruton's Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling

Molecular pharmacology, 2017-03, Vol.91 (3), p.208-219

2017

Volltextzugriff (PDF)

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models

The Journal of immunology (1950), 2019-05, Vol.202 (10), p.2888-2906

2019

Volltextzugriff (PDF)

Natural product glycorandomization

Bioorganic & medicinal chemistry, 2004-04, Vol.12 (7), p.1577-1584

2004

Volltextzugriff (PDF)

Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit

Bioorganic & medicinal chemistry letters, 2018-09, Vol.28 (17), p.2939-2944

2018

Volltextzugriff (PDF)

Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk

Bioorganic & medicinal chemistry letters, 2018-11, Vol.28 (21), p.3419-3424

2018

Volltextzugriff (PDF)

Btk inhibition treats TLR7/IFN driven murine lupus

Clinical immunology (Orlando, Fla.), 2016-03, Vol.164, p.65-77

2016

Volltextzugriff (PDF)

Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression

ACS medicinal chemistry letters, 2023-05, Vol.14 (5), p.566-576

2023

Volltextzugriff (PDF)

Structure-Based Enhancement of the First Anomeric Glucokinase

Chembiochem : a European journal of chemical biology, 2004-07, Vol.5 (7), p.992-996

2004

Volltextzugriff (PDF)

Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitors

Bioorganic & medicinal chemistry letters, 2018-11, Vol.28 (20), p.3307-3311

2018

Volltextzugriff (PDF)

Infection control in nursing education

The Australian nursing journal, 2009-10, Vol.17 (4), p.42

2009

Volltextzugriff (PDF)

Re-shaping Digital Reading

The international journal of the book, 2012, Vol.9 (3), p.33-42

Liu, Lesley

2012

Volltextzugriff (PDF)

SAR and evaluation of novel 5H-benzo[c][1,8]naphthyridin-6-one analogs as Aurora kinase inhibitors

Bioorganic & medicinal chemistry letters, 2013-05, Vol.23 (10), p.3081-3087

2013

Volltextzugriff (PDF)

Synthesis and immunochemistry of Lewis Y analogs

Liu, Lesley Mae Lin

2003

Volltextzugriff (PDF)

Structure-Based Engineering of E. coli Galactokinase as a First Step toward In Vivo Glycorandomization

Chemistry & biology, 2005-06, Vol.12 (6), p.657-664

2005

Volltextzugriff (PDF)

Natural Product Glycorandomization

ChemInform, 2004-05, Vol.35 (21), p.no-no

2004

Volltextzugriff (PDF)

Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population

PloS one, 2022-08, Vol.17 (8), p.e0272721-e0272721

2022

Volltextzugriff (PDF)

High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells

Proceedings of the National Academy of Sciences - PNAS, 2014-02, Vol.111 (6), p.2349-2354

2014

Volltextzugriff (PDF)

The interleukin-4/PPARγ signaling axis promotes oligodendrocyte differentiation and remyelination after brain injury

PLoS biology, 2019-06, Vol.17 (6), p.e3000330-e3000330

2019

Volltextzugriff (PDF)

RECIST 1.1—Update and clarification: From the RECIST committee

European journal of cancer (1990), 2016-07, Vol.62, p.132-137

2016

Volltextzugriff (PDF)

Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors

Proceedings of the National Academy of Sciences - PNAS, 2014-08, Vol.111 (31), p.11365-11370

2014

Volltextzugriff (PDF)

1 – 25 von 476

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(444)
Mit Volltextzugriff
(406)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(475)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases

Discovery of Affinity‐Based Probes for Btk Occupancy Assays

Understanding User-Librarian Interaction Types in Academic Library Microblogging: A Comparison Study in Twitter and Weibo

BCL2L1 is associated with γ-globin gene expression

Creation of the First Anomeric D/L-Sugar Kinase by Means of Directed Evolution

Ability of Bruton's Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models

Natural product glycorandomization

Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit

Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk

Btk inhibition treats TLR7/IFN driven murine lupus

Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression

Structure-Based Enhancement of the First Anomeric Glucokinase

Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitors

Infection control in nursing education

Re-shaping Digital Reading

SAR and evaluation of novel 5H-benzo[c][1,8]naphthyridin-6-one analogs as Aurora kinase inhibitors

Synthesis and immunochemistry of Lewis Y analogs

Structure-Based Engineering of E. coli Galactokinase as a First Step toward In Vivo Glycorandomization

Natural Product Glycorandomization

Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population

High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells

The interleukin-4/PPARγ signaling axis promotes oligodendrocyte differentiation and remyelination after brain injury

RECIST 1.1—Update and clarification: From the RECIST committee

Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors

Suchergebnisse filtern